Medicure - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsMedicure

Medicure(MCU)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Annual sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Aggrastat	Tirofiban	1998-05-14		Myocardial infarction , Coronary disease , Unstable angina
Zypitamag	Pitavastatin magnesium	2017-07-14	2024-2031	Hypercholesterolemia , Hypertriglyceridemia , Hyperlipoproteinemias

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

renal insufficiency

,

myocardial infarction

,

acute coronary syndrome

,

unstable angina

,

,

percutaneous coronary intervention

Polyglycolic acid

healthy volunteers/patients

,

pancreatic ductal carcinoma

,

gastrointestinal neoplasms

,

intestinal neoplasms

,

psoriatic arthritis

,

systemic lupus erythematosus

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

philadelphia chromosome

,

lymphoid leukemia

,

head and neck neoplasms

,

,

pancreatic neoplasms

,

colonic neoplasms

,

residual neoplasm

,

biliary tract neoplasms

,

hematologic neoplasms

,

ovarian neoplasms

,

fallopian tube neoplasms

,

renal cell carcinoma

,

urologic neoplasms

,

triple negative breast neoplasms

,

,

transitional cell carcinoma

,

squamous cell neoplasms

,

adenocarcinoma of lung

,

esophageal neoplasms

,

,

polyneuropathies

,

rectal neoplasms

,

non-small-cell lung carcinoma

,

,

colorectal neoplasms

,

,

malignant mesothelioma

,

,

,

stomach neoplasms

,

squamous cell carcinoma of head and neck

,

,

breast neoplasms

,

microsatellite instability

,

squamous cell carcinoma

,

rheumatoid arthritis

,

,

premature birth

,

geriatric assessment

Microcrystalline cellulose

healthy volunteers/patients

,

gram-positive bacterial infections

,

,

,

hepatic insufficiency

,

,

,

,

,

castration-resistant prostatic neoplasms

,

urologic neoplasms

,

urinary bladder neoplasms

,

small cell carcinoma

,

urethral neoplasms

,

transitional cell carcinoma

,

neuroendocrine tumors

,

neuroendocrine carcinoma

,

,

,

hodgkin disease

,

cytomegalovirus infections

,

prediabetic state

,

small cell lung carcinoma

,

,

,

,

,

,

gestational diabetes

,

glucose intolerance

,

pneumococcal pneumonia

,

,

thyroid neoplasms

,

,

breast neoplasms

,

non-hodgkin lymphoma

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

pneumococcal infections

,

,

communicable diseases

,

renal insufficiency

,

bacterial skin diseases

,

chronic renal insufficiency

,

bacterial infections

,

rheumatoid arthritis

,

,

prostatic neoplasms

,

,

bacterial vaginosis

,

vulvovaginal candidiasis

,

vaginal diseases

,

,

,

acquired immunodeficiency syndrome

,

antibiotic prophylaxis

,

,

chronic kidney failure

,

kidney diseases

,

,

hyperlipidemias

,

islets of langerhans transplantation

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

,

,

atherosclerosis

,

,

cystic fibrosis

,

hospitalization

,

,

,

,

,

adipose tissue neoplasms

,

,

cardiovascular diseases

,

type 1 diabetes mellitus

pregnancy complications

,

hyperemesis gravidarum

,

,

,

,

morning sickness

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use